Buprenorphine by video visit versus in-person care
Part of Mental health clinical trials.
This trial tests whether taking buprenorphine (a medicine for opioid use disorder) through telemedicine works as well as standard in-person care. You may be enrolled if you’re seeking treatment for opioid use disorder and can safely follow study steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have opioid use disorder (OUD) based on DSM-5 criteria
- You are voluntarily looking for buprenorphine treatment for OUD
- You can understand the study, sign consent, and follow study visits and rules
- You are not in methadone or buprenorphine (or Vivitrol) maintenance treatment at the same time
- You are not allergic or unable to tolerate buprenorphine
- You don’t have serious safety concerns like untreated severe medical problems, high risk of suicide/violence, or certain severe psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a telehealth program can help people with opioid use disorder get and stay on buprenorphine treatment. It aims to make care more accessible for those in vulnerable situations.
This study tests whether a tailored telehealth program can help people with opioid use disorder get better access to treatment. It is designed for patients who are already receiving or starting treatment with buprenorphine at Prevention Point Philadelphia.
This study compares follow-up care after an emergency department visit for opioid addiction: either through telehealth (video visits) or in-person appointments. The goal is to see which method helps people stay in treatment after they leave the ED.
This study tests whether treatment for opioid use disorder can be done effectively through telehealth (video calls and texts). It is designed for people who are not currently on medication for opioid addiction and want to start treatment from home.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.